Hepion Pharmaceuticals, Inc. (HEPA) stock
HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Hepion Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Hepion Pharmaceuticals's revenue for the twelve months ending Mar 31, 2024 was $0. For fiscal 2023 it was $0.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | – |
| FY2022 | Dec 31, 2022 | $0 | – |
| FY2021 | Dec 31, 2021 | $0 | – |
| FY2020 | Dec 31, 2020 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $0 | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $0 | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $0 | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $0 | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $0 | – |
See a number that looks wrong?